State senator leading another charge for medical marijuana

A Louisville senator is hoping to add Kentucky to the list of 18 states that have legalized medical marijuana. State senator Perry Clark has introduced a bill for the 2013 legislative session that would legalize pot for medical use in Kentucky.

  He and the group of Kentuckians for Medical Marijuana were celebrating at Clark’s Louisville home Sunday because there will be a public hearing on August 21 in the Health and Welfare joint senate house committee.  “It’s time. 40 percent of the states have already passed medical marijuana laws and Kentucky is kind of fallen behind on that. The science is far on our side. Cannabis is medicine. It’s medicine in its many forms,”

Clark said. Senator Clark introduced a similar bill last year but it failed to gain any traction. Opponents of the bill fear legalizing marijuana for medical use would also open the door for more illegal marijuana operations in the state.

Read More

  Grow All The Cannabis You Want Indoors

Scientists Discover Another Way Marijuana Helps The Brain Grow

Research shows for the first time that CBD, like THC, can promote the growth of brain cells

In 2005, Canadian researchers made a groundbreaking discovery that would forever discredit the myth that marijuana causes brain damage. What they found was an opposite effect. That is, THC – the main chemical in marijuana and the reason why users get ‘high’ – can actually cause new brain cells to grow.

The process of brain growth is called neurogenesis and does not usually improve with drug use. Marijuana use is a different story, explained Xia Zhang, M.D, Ph.D., associate professor at the University of Saskatchewan and lead author of the study:

“Most ‘drugs of abuse’ suppress neurogenesis. Only marijuana promotes neurogenesis.”

Still, THC is not the only chemical found in marijuana and, eight years later, a team from Brazil is giving marijuana users more reason to celebrate. Their study, published in the July issue of The International Journal of Neuropsychopharmacology, shows that cannabidiol (CBD) can help your brain grow too.

Looking to investigate the effects of CBD on anxiety and depression in rodents, the researchers went to the source – a part of the brain called the hippocampus. The hippocampus regulates emotion and cognitive function and is also the only area of the adult brain that can grow.

The hippocampus plays a role in emotion, memory, and learning.

While previous studies have found CBD to have beneficial effects on anxiety and depression, the new study is the first to explain why.

What the scientists found was that CBD, just like THC, also causes brain cells in the hippocampus to grow. This, they say, could explain why previous studies identified CBD as an effective treatment for mood disorders.

“Our results indicate that chronic CBD administration, by promoting neurogenesis, favours a similar anxiolytic response in stressed mice.”

Likewise, other studies have linked depression, anxiety and stress – and even problems with learning and memory – to a lack of adult neurogenesis. Although this can be brought on by frequent substance use (expect for marijuana), neurogenesis also slows down naturally as you age.

But now there is hope, says the team from Brazil. A new understanding of how the brain reacts to CBD, along with other compounds in marijuana, “opens the door for their use to manage psychiatric symptoms in disorders such as ageing, stress and neuroinflammation.”

Read More

To Dab Or Not To Dab?

With each passing month, the popularity – and controversy – of butane hash oil (BHO) and the phenomenon surrounding it (known as “dabbing”) continues to grow in the cannabis community. Some hail it as a miracle medicine, a quantum leap forward in stoner evolution. Others criticize it, pointing to the potential dangers involved in both making and ingesting it, as well as possible negative effects on the public’s increasingly favorable attitude toward marijuana. Here at HIGH TIMES, it’s our duty to cover this issue as honestly and responsibly as we can – addressing any genuine concerns and dispelling unwarranted fears. To that end, we consulted some of the industry’s most knowledgeable experts on the subject of cannabis extracts and their effect on the human body. Here’s what they had to say.

Solvent vs Nonsolvent Extraction

The first question to be addressed is: What’s the difference between solvent extracts and traditional hash? Well, aside from appearance, the biggest difference is the process involved in making them. While traditional hash is made using sieves (wet or dry) to separate the trichomes from the plant, extract hash is made by “blasting” a chemical solvent (i.e., butane, CO2) through the plant matter, then “purging” the solvent away. But these solvents don’t just extract the trichomes – they also pull substances from other parts of the plant.

“You’re getting a lot of extra goodies that come out in those solvent extracts,” observes Bob Melamede, Ph.D. An associate professor of biology at the University of Colorado and the president/CEO of Cannabis Science Inc., Dr. Melamede is one of the world’s few experts on the human endocannabinoid system. “Aside from the oils, there are all sorts of compounds that come out that probably have beneficial value,” he says. “We’ve got indications that there are differences in the effects, pain relief properties and potentially other important phenomena. We don’t really know at this point ... all we know is that this plant is quite the magical chemistry set.”

It’s also widely believed that BHO boasts a higher concentration of THC and is therefore much stronger than traditional hashish. But is this really true? As the cannabis critic for Denver’s Westword alt-newspaper, William Breathes is paid to sample and review a wide array of cannabis products – and according to his experience, it is stronger. “When you look at the percentage of cannabinoids per weight, it seems you’re pulling out more THC with butane than with ice water,” he says.



But there are those who disagree – such as Selecta Nikka T, owner and operator of Colorado’s Essential Extracts. “It’s such a new phenomenon that we really don’t have enough data to show that BHO is getting higher test results than water extraction of the same strain, or if there are any dangers to it,” he asserts. “I prefer the solventless method, because we can retain terpenes a lot better than most solvents, and I don’t have to worry about anything being left over in my product.”

Another of Denver’s extraction experts is Daniel “Big D” de Sailles, a partner at Top Shelf Extracts, who isn’t quite as skeptical. “I’m a 100 percent proponent of BHO, because I’ve seen it make people’s pain just evaporate,” he states. “As medicine, it helps with both harm reduction – it practically cures withdrawal symptoms in people who are alcoholics or addicted to speed or pharmaceuticals – and pain management. It works every single time, and it’s easier to regulate your dosage. You take a fraction of a percent of a gram, and you’re fully medicated and exactly where you want to be.”

So which is better, butane or solventless? Until more analysis is done comparing the chemical composition of the plant material to the solvent extracts, we won’t know the real differences. But according to Amarimed of Colorado’s Alan Shackelford, MD, it’s not really a matter of “better” or “worse” – just what suits a patient’s individual needs and preferences.

“There isn’t necessarily one method that’s superior to another,” he explains. “Concentrates can be provided in a variety of ways ... different options for different conditions that vary from person to person, as it should be.”

Read More Grow Cannabis Indoors

New Hampshire Legislature passes medical marijuana bill

The N.H. Legislature overwhelmingly passed legislation Wednesday legalizing medical marijuana. But the vote did not fall entirely along party lines among Monadnock Region lawmakers.

House Bill 573 sailed through the N.H. House, 284-66. The Senate also passed the bill on a voice vote.

In the region, it passed by a 27-3 vote in the House.

State Rep. William Butynski, D-Hinsdale, who voted against the bill in March, switched his vote on Wednesday.

“The Senate changed the bill to incorporate changes recommended by the governor,” he said. “And so, I’m not sure I felt good, but I felt OK voting for it.”

Butynski said his main concern about passing such a bill is “the message it sends to young people. I don’t want them to think, ‘Well, it’s OK to use for medical (purposes) so it’s OK for me to use it,’ because that’s really not the case.”

The bill makes it legal for people with serious health conditions to possess up to 2 ounces of marijuana for therapeutic use with a doctor’s prescription. Medical conditions or diseases that qualify people for medical marijuana include cancer, glaucoma, HIV, AIDS, hepatitis C, ALS, muscular dystrophy, Crohn’s disease, Alzheimer’s disease and multiple sclerosis.

Post-traumatic stress disorder was removed from the list during legislative negotiations over the final version of the bill, as was a provision that would have allowed patients or their caregivers to grow their own marijuana.

Patients will be allowed to buy marijuana at four dispensaries across the state whose locations are yet to be determined. Those sites are expected to open in 2015.

The House passed an earlier version of the bill in March, but Gov. Maggie Hassan expressed concerns about the home-growing provision and other aspects. After that provision was dropped in the Senate, she promised to sign the bill into law.

Before entering politics, Butynski, who has a Ph.D. in psychology, worked for 35 years in alcohol and drug treatment and prevention, he said.

“Marijuana, in fact, can be a dangerous drug, particularly for young people,” he said. “People can get addicted to marijuana. A number of people will say, ‘Oh that can’t happen,’ and those were people who maybe tried it 10 or 20 years ago, when it wasn’t the same potency.”

Still, Butynski was swayed by the bill’s restrictiveness.

“It may even be the bill can be improved over time,” he said. “I certainly recognize that some people believe very wholeheartedly that they are helped by using cannabis in a therapeutic way.”

State Rep. Henry A.L. Parkhurst, D-Winchester, was the only Democrat in the region to vote against the bill, as he did in March.

“There is still a federal ban on marijuana, and that’s my biggest sticking point,” he said. “I took an oath to uphold the United States Constitution. It’s a sticky wicket here. There are those on both sides that are very passionate with it.

“If a doctor prescribes it, then I think it should be legal, and as soon as the federal government says OK, you’ll have my vote,” he said. “I hate to hear about people suffering, and that something that can help them is illegal and criminal, but let’s do it legally,” at the federal level, he said.

State Rep. Charles F. Weed, D-Keene, however, believes the bill doesn’t go far enough.

“I think that our craze against marijuana is a kind of prohibition, so I’ve been in favor of ending that policy against many drugs for a long time,” he said. “I’m disappointed that we did not provide ways of taking care of those people who have the need in the next few years until we have dispensaries (in 2015), so they could use prescriptions to go to Maine or Vermont,” states that already passed medical marijuana laws.

State Sen. Bob Odell, R-Lempster, whose district includes the local towns of Acworth, Antrim, Bennington, Langdon, Marlow and Stoddard, did not support the bill.

“I’ve been very straightforward from day one,” he said Wednesday night. “I think it’s wrong to set up a separate system for just marijuana.

“It baffles me why ... we can’t come to the table and do something responsible,” he said. “Whatever the benefits are, have it come through the regular drug distribution system, including your local pharmacy, and have oversight and regulation and FDA approval.”

While Odell said he’s supportive of the concept of medical marijuana, “particularly for people in late stages of life ... I can’t imagine why we’re putting in 50 little drug businesses across the country.”

State Rep. Steven Smith, R-Charlestown, said it was easy for him to say “yea.”

“When you look at somebody that’s suffering and it isn’t ever going to get better, it’s hard to deny them that comfort,” he said Wednesday night.

Smith said that while some lawmakers had concerns that “we’ll get a lot of 20-year-olds who will go to the doctor and say, ‘Dude, my back hurts,’ “ he’s much more concerned about the problems presented by legal prescription medication such as Oxycontin.

“Others felt this would be a gateway (to legalization), but you have to vote on the bill that’s in front of you,” he said. “If we find the restrictions in this bill aren’t tight enough, we can work on it again next session.”

Susan M. MacNeil, executive director for AIDS Services for the Monadnock Region, said she was thrilled to hear the news of the bill’s passing because it will help her agency’s clients.

“The most important consideration for anyone who is HIV-positive is being able to tolerate their medication regimen, and if our clients can be helped in that regard, then that is something we certainly support,” she said.

Typical side effects for HIV and AIDS medications include extreme nausea, vomiting and inability to eat, she said.

“That’s the key with HIV meds; you don’t start and stop, you have to keep taking it,” she said. “This is just one more tool in our toolbox to help keep people with HIV as healthy as possible ... so to know the Legislature has done the right thing, the compassionate thing, that’s all good.”

Read More

Grow Cannabis Indoors

The Endocannabinoid System - Educational Scientific Understanding

The endogenous cannabinoid system, named after the plant that led to its discovery, is perhaps the most important physiologic system involved in establishing and maintaining human health. Endocannabinoids and their receptors are found throughout the body: in the brain, organs, connective tissues, glands, and immune cells. In each tissue, the cannabinoid system performs different tasks, but the goal is always the same: homeostasis, the maintenance of a stable internal environment despite fluctuations in the external environment.

Cannabinoids promote homeostasis at every level of biological life, from the sub-cellular, to the organism, and perhaps to the community and beyond. Here's one example: autophagy, a process in which a cell sequesters part of its contents to be self-digested and recycled, is mediated by the cannabinoid system. While this process keeps normal cells alive, allowing them to maintain a balance between the synthesis, degradation, and subsequent recycling of cellular products, it has a deadly effect on malignant tumor cells, causing them to consume themselves in a programmed cellular suicide. The death of cancer cells, of course, promotes homeostasis and survival at the level of the entire organism.

Endocannabinoids and cannabinoids are also found at the intersection of the body's various systems, allowing communication and coordination between different cell types. At the site of an injury, for example, cannabinoids can be found decreasing the release of activators and sensitizers from the injured tissue, stabilizing the nerve cell to prevent excessive firing, and calming nearby immune cells to prevent release of pro-inflammatory substances. Three different mechanisms of action on three different cell types for a single purpose: minimize the pain and damage caused by the injury.

The endocannabinoid system, with its complex actions in our immune system, nervous system, and all of the body's organs, is literally a bridge between body and mind. By understanding this system we begin to see a mechanism that explains how states of consciousness can promote health or disease.

In addition to regulating our internal and cellular homeostasis, cannabinoids influence a person's relationship with the external environment. Socially, the administration of cannabinoids clearly alters human behavior, often promoting sharing, humor, and creativity. By mediating neurogenesis, neuronal plasticity, and learning, cannabinoids may directly influence a person's open-mindedness and ability to move beyond limiting patterns of thought and behavior from past situations. Reformatting these old patterns is an essential part of health in our quickly changing environment.

What Are Cannabinoid Receptors?

Sea squirts, tiny nematodes, and all vertebrate species share the endocannabinoid system as an essential part of life and adaptation to environmental changes. By comparing the genetics of cannabinoid receptors in different species, scientists estimate that the endocannabinoid system evolved in primitive animals over 600 million years ago.

While it may seem we know a lot about cannabinoids, the estimated twenty thousand scientific articles have just begun to shed light on the subject. Large gaps likely exist in our current understanding, and the complexity of interactions between various cannabinoids, cell types, systems and individual organisms challenges scientists to think about physiology and health in new ways. The following brief overview summarizes what we do know.

Cannabinoid receptors are present throughout the body, embedded in cell membranes, and are believed to be more numerous than any other receptor system. When cannabinoid receptors are stimulated, a variety of physiologic processes ensue. Researchers have identified two cannabinoid receptors: CB1, predominantly present in the nervous system, connective tissues, gonads, glands, and organs; and CB2, predominantly found in the immune system and its associated structures. Many tissues contain both CB1 and CB2 receptors, each linked to a different action. Researchers speculate there may be a third cannabinoid receptor waiting to be discovered.

Endocannabinoids are the substances our bodies naturally make to stimulate these receptors. The two most well understood of these molecules are called anandamide and 2-arachidonoylglycerol (2-AG). They are synthesized on-demand from cell membrane arachidonic acid derivatives, have a local effect and short half-life before being degraded by the enzymes fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL).

Phytocannabinoids are plant substances that stimulate cannabinoid receptors. Delta-9-tetrahydrocannabinol, or THC, is the most psychoactive and certainly the most famous of these substances, but other cannabinoids such as cannabidiol (CBD) and cannabinol (CBN) are gaining the interest of researchers due to a variety of healing properties. Most phytocannabinoids have been isolated from cannabis sativa, but other medical herbs, such as echinacea purpura, have been found to contain non-psychoactive cannabinoids as well.

Interestingly, the marijuana plant also uses THC and other cannabinoids to promote its own health and prevent disease. Cannabinoids have antioxidant properties that protect the leaves and flowering structures from ultraviolet radiation - cannabinoids neutralize the harmful free radicals generated by UV rays, protecting the cells. In humans, free radicals cause aging, cancer, and impaired healing. Antioxidants found in plants have long been promoted as natural supplements to prevent free radical harm.

Laboratories can also produce cannabinoids. Synthetic THC, marketed as dronabinol (Marinol), and nabilone (Cesamet), a THC analog, are both FDA approved drugs for the treatment of severe nausea and wasting syndrome. Some clinicians have found them helpful in the off-label treatment of chronic pain, migraine, and other serious conditions. Many other synthetic cannabinoids are used in animal research, and some have potency up to 600 times that of THC.

Cannabis, The Endocannabinoid System, And Good Health

As we continue to sort through the emerging science of cannabis and cannabinoids, one thing remains clear: a functional cannabinoid system is essential for health. From embryonic implantation on the wall of our mother's uterus, to nursing and growth, to responding to injuries, endocannabinoids help us survive in a quickly changing and increasingly hostile environment. As I realized this, I began to wonder: can an individual enhance his/her cannabinoid system by taking supplemental cannabis? Beyond treating symptoms, beyond even curing disease, can cannabis help us prevent disease and promote health by stimulating an ancient system that is hard-wired into all of us?

I now believe the answer is yes. Research has shown that small doses of cannabinoids from marijuana can signal the body to make more endocannabinoids and build more cannabinoid receptors. This is why many first-time marijuana users don't feel an effect, but by their second or third time using the herb they have built more cannabinoid receptors and are ready to respond. More receptors increase a person's sensitivity to cannabinoids; smaller doses have larger effects, and the individual has an enhanced baseline of endocannabinoid activity. I believe that small, regular doses of marijuana might act as a tonic to our most central physiologic healing system.

Many physicians cringe at the thought of recommending a botanical substance, and are outright mortified by the idea of smoking a medicine. Our medical system is more comfortable with single, isolated substances that can be swallowed or injected. Unfortunately, this model significantly limits the therapeutic potential of cannabinoids.

Unlike synthetic derivatives, herbal marijuana may contain over one hundred different cannabinoids, including THC, which all work synergistically to produce better medical effects and less side effects than THC alone. While marijuana is safe and works well when smoked, many patients prefer to use a vaporizer or cannabis tincture. Scientific inquiry and patient testimonials both indicate that herbal marijuana has superior medical qualities to synthetic cannabinoids.

Read More

Grow Cannabis Indoors

Could cannabis have antipsychotic properties?

In addition to psychoactive chemicals, cannabis contains components that may have a protective effect in mental illness.

When Dr Tim Karl, a senior scientist at NeuRA, says he believes that marijuana has potential as a treatment for schizophrenia, he’s adding fuel to a very contentious fire.

Marijuana – or cannabis, as it is otherwise known – is a controversial substance, particularly in light of evidence that it can trigger the development of schizophrenia in some people.

But cannabis, says Dr Karl, is made up of dozens of chemical components that can have widely varying effects on the brain.

Dr Karl and his team are investigating a component called cannabidiol, or CBD. CBD is thought to reduce the psychoactive effects of the most well-known component of cannabis, THC.

THC (Δ9-tetrahydrocannabinol) is the main active chemical in cannabis, and is known to increase psychotic symptoms in people with schizophrenia.

"We’re looking at whether CBD just has the capacity to block the effects of THC, or whether it has an independent anti-psychotic effect," says Dr Karl.

"If CBD is shown to have anti-psychotic properties, I believe it could have therapeutic potential."

First hand experience

Dr Karl says his interest in schizophrenia developed in part from working in an emergency psychiatric ward in Germany after he finished high school.

"I saw people who had had psychotic episodes, people who were suicidal. I felt deeply sorry for them because their options were so limited," he says.

Dr Karl saw first-hand the limited effectiveness of the drugs available to those patients in the psychiatric ward – and the need to develop more effective alternatives with fewer side-effects.

The majority of Dr Karl’s work will be done in mice bred to carry a genetic risk factor for schizophrenia, a gene called neuregulin 1These mice are genetically predisposed for schizophrenia(NRG1). These mice are susceptible to the effects of THC in a similar way to people who are genetically predisposed to experiencing psychosis if they use cannabis during adolescence.

The team has already begun looking at the effects of CBD in mice using various strains of cannabis with different THC:CBD ratios.

"This research will tell us whether particular strains of cannabis are more likely than others to induce psychotic-like symptoms, based on their THC:CBD ratio," says Dr Karl.

Dr Karl says this research will clarify whether CBD has a protective effect and therefore potential as an anti-psychotic therapeutic.

They will also gain a better understanding of the risks involved in early cannabis abuse and the interactive nature of genetic and environmental risk factors for schizophrenia.

"I don't believe that my work will cure schizophrenia, but it will give insights into the biological mechanisms of the disorder and might help us develop better treatments," he says.

Read More

Grow Cannabis Indoors

Cannabidiol (CBD): Fighting Inflammation & Aggressive Forms of Cancer

Marijuana contains at least 60 known chemicals called cannabinoids, which activate cannabinoid receptors in your body. Tetrahydrocannabinol, or THC, is the main component responsible for the psychoactive effects, or “high,” marijuana is known for. While THC is known to have some medicinal value, there has been recent investigation into a new cannabinoid that is rumored to have more medicinal benefits than any single pharmaceutical drug on the market.

What is Cannabidiol (CBD)?

This cannabinoid is known as Cannabidiol (CBD), and is the second most abundant cannabinoid in cannabis. Research done by G.W. Pharmaceuticals suggests that CBD could be used for treating symptoms of rheumatoid arthritis and other autoimmune diseases, diabetes, nausea, bowel disorders, and many other hard-to-control side effects. According to an article from Projectcbd.com, CBD has even demonstrated neuroprotective effects, and its anti-cancer potential is currently being explored.

While it was originally believed that THC is a breakdown product of CBD, it is now known that both THC and CBD are actually metabolites of their decarboxylated acidic forms, THCa and CBDa. These acidic precursors are decarboxylated (essentially dried) by heat or extraction to produce THC and CBD; only then do they become psychoactive. The compound has medicinal benefits without the “high” that some patients do not desire. This makes CBD appealing to patients who are looking for an alternative to their current meds, which often have opiate-like effects.

“After years of growers aiming to boost THC percentages in their crops, many growers have switched to focusing on producing CBD-rich strains because of the increasing demand by medical users.”

Cannabidiol is even known to counteract some of the effects of THC like the “munchies.” Just as THC increases our appetite, CBD suppresses it, which could be ideal for patients watching their figure. CBD just might be a key ingredient in a future weight loss drug, who knows? There is one exception to the theory that CBD suppresses appetite, but it is a blessing as well. Many people who have difficulty eating due to their stress or anxiety can use CBD to get rid of that sick feeling in their chest or stomach, allowing them to eat again once their anxiety subsides.

CBD Used To Treat a Number of Symptoms in Patients

Cannabidiol is what gives cannabis its’ sedative effect, and has been known to ease a number of symptoms from difficult conditions.  There has actually been a substantial amount of experiments done on cannabidiol that has proved its healing powers. Dr. Sean McAllister, a scientist from the Pacific Medical Center in San Francisco, made an astounding discovery about CBD. McAllister has been studying cannabinoid compounds for 10 years now in search of new therapeutic interventions for various cancers. He discovered that cannabidiol is a potent inhibitor of cancer cell proliferation, metastasis, and tumor growth. Results of his experiments on breast cancer show that the number of cancer cells diminished as more CBD was applied. Essentially, CBD may be a generally effective way to switch off the cancer-causing gene, providing patients with a non-toxic therapy to treat aggressive forms of cancer.

“CBD could be used for treating symptoms of rheumatoid arthritis and other autoimmune diseases, diabetes, nausea, bowel disorders, and many other hard-to-control side effects.”

Raphael Mechoulam of the Hebrew University, Jerusalem, and Faculty of Medicine has been studying cannabinoids for almost 50 years. Mechoulam gave a talk on cannabidiol on the 45^th year of involvement in the field in which he spoke about a number of experiments being done on cannabidiol. He described an experiment that was done in Brazil in which a 200mg/day dosage of CBD was added to the anticonvulsants epilepsy patients were currently taking. Over the course of several months only 1 of the 7 patients showed no improvement; three became seizure-free; one experienced only one or two seizures, and two experienced reduced severity and occurrence of seizures.

CBD Proven to Reduce Inflammation

A colleague of Mechoulam’s, Marc Feldman at Imperial College, London, tested CBD on mice that had a version of rheumatoid arthritis and found that it reduced inflammation by 50% at the right dosage. Cardiologists working with mice at the Hebrew University have found that a dosage of CBD immediately following a heart attack can reduce infarct size by about 66%. Probably one of the most notable studies conducted by Mechoulam was on mice bred to have a version of type-1 diabetes. The diabetes manifests around 14 weeks so the mice were treated for the first 7 weeks of their life, then again in another 7 weeks. He concluded that only 30% had developed diabetes compared to the 90-100% given the placebo. He then repeated the experiment where the CBD wasn’t introduced until 14 weeks when the diabetes first developed. They were then tested at 24 weeks of age and again only 30% of the treated mice were found to have diabetes.

“CBD did not just prevent onset, it blocked the development of diabetes.” - Mechoulam says.

Since CBD is a function of an increase in temperature, cannabis is heat activated in the testing process to get measurements. CBD typically shows up under, or around 1% in most strains. Since most strains have this low percentage it is sometimes hard to find a CBD-rich plant with low THC percentages as to avoid the ‘high’. However, that doesn’t mean that these CBD-rich strains don’t exist. “Cannatonic” is one known popular CBD-rich strain which is known to contain 6.5% CBD by weight, and the same amount of THC, making for one of the most medicinal strains out there. Harlequin, Jamaican Lion and Omrita Rx3 have been tested several times by several labs and are in the neighborhood of 8-9% CBD and 5.5-6% THC —about a 3:2 ratio.

We have only begun to scratch the surface of understanding this miraculous cannabinoid. While significant discoveries have been made about the medicinal benefits of Cannabidiol, there is much left to reveal about this cannabinoid. You can read about recent developments in ProjectCBD.org’sCBDiary, a catch-all column for news generated by patients, doctors, dispensaries, growers, plant breeders, pharmacologists, the industry, the government —all the players— as the CBD story unfolds.

Read More

Grow Cannabis Indoors

This post brought to you in part by godaddy.com

Indisputable Evidence That Cannabis May Be The Most Nutritional Vegetable In The World

Grow Cannabis Indoors